SlideShare ist ein Scribd-Unternehmen logo
1 von 11
Rate of Excretion Method
Presented by
Gurudayal Yadav
(M.Pharm 1st year)
Enrollment no:18022020011
INTRODUCTION
• In the absence of plasma level-time data , useful information can
still be obtained from urine data regarding elimination kinetics of
a drug.
Advantages:
• Method is useful when there is lack of sufficiently sensitive
analytical techniques to measure concentration of drugs in plasma
with accuracy.
• Method is non-invasive
• Method is more convenient.
• Less sensitive analytical method is required for determining urine
drug concentration as compared to plasma concentrations.
• First-order elimination, excretion and absorption rate constants
and fraction excreted unchanged can be computed from such
data.
25-Mar-19 2
• Direct measurement of bioavailability.
• When coupled with plasma level-time data, it can also be used to
estimate renal clearance of unchanged drug according to
following equation:
• If Vd is known, total systemic clearance and non renal clearance
can also be calculated.
• One cannot, however, compute Vd and ClT from urine data alone.
One must also remember that urinary excretion data is not an
accurate substitute for the plasma level data. At best, the data
can be employed as a rough estimate of the pharmacokinetic
parameters.
25-Mar-19 3
Criteria for obtaining valid Urinary excretion
data
 A significant amount of drug must be excreted unchanged in the
urine (at least 10%).
 The analytical method must be specific for the unchanged drug;
metabolites should not interfere
 Water-loading should be done by taking 400 ml of water after
fasting overnight, to promote diuresis and enable collection of
sufficient urine samples
 Before administration of drug, the bladder must be emptied
completely after 1 hour from water-loading and the urine sample
taken as blank. The drug should then be administered with 200 ml
of water and should be followed by 200 ml given at hourly
intervals for the next 4 hours.
25-Mar-19 4
 Volunteers must be instructed to completely empty their bladder
while collecting urine samples.
 Frequent sampling should be done in order to obtain a good
curve.
 During sampling, the exact time and volume of urine excreted
should be noted.
 An individual collection period should not exceed one biological
half-life of the drug and ideally should be considerably less.
 Urine samples must be collected for at least 7 biological half-
lives in order to ensure collection of more than 99% of excreted
drug.
 Changes in urine pH and urine volume may alter the urinary
excretion rate.
25-Mar-19 5
25-Mar-19 6
Determination of KE from Urinary excretion data
• The first-order elimination (and excretion) rate constants can be
computed from urine data by two methods
1. Rate of excretion method, and
2. Sigma-minus method.
25-Mar-19 7
1. RATE OF EXCRETION METHOD
• The rate of urinary drug excretion(dXu/dt) is directly proportional
to the amount of drug in the body(X) and written as-
• Where, Ke =first order urinary excretion rate constant.
• According to first-order disposition kinetics,
• Substitution it in above equation yields-
25-Mar-19 8
 Transforming the log form the equation become-
25-Mar-19 9
The above equation states that a semi log plot of rate of excretion
versus time yields a straight line with slope –KE/2.303 .
It must therefore be remembered that the slope of such an
excretion rate versus time plot is related to elimination rate
constant KE and not to excretion rate constant Ke.
The excretion rate constant can be obtained from the Y-intercept
(log Ke Xo). Elimination half-life and non renal elimination rate
constant can then be computed from KE and Ke.
• An advantage of excretion rate method is that for drugs having
long half-lives, urine may be collected for only 3 to 4 half-lives.
Moreover, there is no need to collect all urine samples since
collection of any two consecutive urine samples yield points on
the rate plot from which a straight line can be constructed
Fig: Semi log plot of excretion rate versus mid-
point time of urine collection period for computing
elimination rate constant after i.v. bolus
administration25-Mar-19 10
25-Mar-19 11

Weitere ähnliche Inhalte

Was ist angesagt?

Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment ModellingPallavi Kurra
 
Compartmental analysis
Compartmental analysisCompartmental analysis
Compartmental analysisSuny Bisshojit
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV InfusionLakshmiChandran20
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Sulekha Rohilla
 
Bioavailability by pradip
Bioavailability by pradipBioavailability by pradip
Bioavailability by pradipPradip Ghori
 
sandeep verapamil ppts
sandeep verapamil pptssandeep verapamil ppts
sandeep verapamil pptssandeep ram
 
Pharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja MPharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja MKarthick Marimuthu
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
One compartmental i.v. infusion
One compartmental i.v. infusionOne compartmental i.v. infusion
One compartmental i.v. infusionDebashis Purohit
 
pharmacokinetics
 pharmacokinetics pharmacokinetics
pharmacokineticsKhadga Raj
 
Seminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelSeminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelDivya Singh
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Manjit Kaur
 
Measurement of bioavailability and concept of equivalence
Measurement of bioavailability and concept of equivalenceMeasurement of bioavailability and concept of equivalence
Measurement of bioavailability and concept of equivalenceRavish Yadav
 

Was ist angesagt? (17)

Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Compartmental analysis
Compartmental analysisCompartmental analysis
Compartmental analysis
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Pharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug AbsorptionPharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug Absorption
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
Bioavailability by pradip
Bioavailability by pradipBioavailability by pradip
Bioavailability by pradip
 
sandeep verapamil ppts
sandeep verapamil pptssandeep verapamil ppts
sandeep verapamil ppts
 
Pharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja MPharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja M
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
One compartmental i.v. infusion
One compartmental i.v. infusionOne compartmental i.v. infusion
One compartmental i.v. infusion
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
pharmacokinetics
 pharmacokinetics pharmacokinetics
pharmacokinetics
 
Seminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelSeminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open model
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling
 
Measurement of bioavailability and concept of equivalence
Measurement of bioavailability and concept of equivalenceMeasurement of bioavailability and concept of equivalence
Measurement of bioavailability and concept of equivalence
 

Ähnlich wie Ppt of nayyer sir copy

Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studiesSonam Gandhi
 
Non Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic ParametersNon Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic ParametersThilak Chandra
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal diseaseAreej Abu Hanieh
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptAditya Sharma
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2ragini Dani
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALSDivya Pushp
 
Renal clearance test
Renal clearance testRenal clearance test
Renal clearance testANUSWARUM
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhRanjeet Singh
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxSaishDalvi
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Muhammad Asim Rana
 
Unified-Drug-Analysis_Hayward_HPLC-2016
Unified-Drug-Analysis_Hayward_HPLC-2016Unified-Drug-Analysis_Hayward_HPLC-2016
Unified-Drug-Analysis_Hayward_HPLC-2016Mark Hayward
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 

Ähnlich wie Ppt of nayyer sir copy (20)

Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Non Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic ParametersNon Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic Parameters
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal disease
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence ppt
 
Chapter08 - 10 Bioavailability & Bioequivalance.ppt
Chapter08 -   10           Bioavailability & Bioequivalance.pptChapter08 -   10           Bioavailability & Bioequivalance.ppt
Chapter08 - 10 Bioavailability & Bioequivalance.ppt
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
Bioavailability-Kinetics.pptx
Bioavailability-Kinetics.pptxBioavailability-Kinetics.pptx
Bioavailability-Kinetics.pptx
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 
Urodynami .pptx
Urodynami .pptxUrodynami .pptx
Urodynami .pptx
 
Renal clearance test
Renal clearance testRenal clearance test
Renal clearance test
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
 
Dose of hd
Dose of hdDose of hd
Dose of hd
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy Basics of Continuous Renal Replacement Therapy
Basics of Continuous Renal Replacement Therapy
 
Unified-Drug-Analysis_Hayward_HPLC-2016
Unified-Drug-Analysis_Hayward_HPLC-2016Unified-Drug-Analysis_Hayward_HPLC-2016
Unified-Drug-Analysis_Hayward_HPLC-2016
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 

Kürzlich hochgeladen

General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxPooja Bhuva
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Amil baba
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Pooja Bhuva
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jisc
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 

Kürzlich hochgeladen (20)

General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 

Ppt of nayyer sir copy

  • 1. Rate of Excretion Method Presented by Gurudayal Yadav (M.Pharm 1st year) Enrollment no:18022020011
  • 2. INTRODUCTION • In the absence of plasma level-time data , useful information can still be obtained from urine data regarding elimination kinetics of a drug. Advantages: • Method is useful when there is lack of sufficiently sensitive analytical techniques to measure concentration of drugs in plasma with accuracy. • Method is non-invasive • Method is more convenient. • Less sensitive analytical method is required for determining urine drug concentration as compared to plasma concentrations. • First-order elimination, excretion and absorption rate constants and fraction excreted unchanged can be computed from such data. 25-Mar-19 2
  • 3. • Direct measurement of bioavailability. • When coupled with plasma level-time data, it can also be used to estimate renal clearance of unchanged drug according to following equation: • If Vd is known, total systemic clearance and non renal clearance can also be calculated. • One cannot, however, compute Vd and ClT from urine data alone. One must also remember that urinary excretion data is not an accurate substitute for the plasma level data. At best, the data can be employed as a rough estimate of the pharmacokinetic parameters. 25-Mar-19 3
  • 4. Criteria for obtaining valid Urinary excretion data  A significant amount of drug must be excreted unchanged in the urine (at least 10%).  The analytical method must be specific for the unchanged drug; metabolites should not interfere  Water-loading should be done by taking 400 ml of water after fasting overnight, to promote diuresis and enable collection of sufficient urine samples  Before administration of drug, the bladder must be emptied completely after 1 hour from water-loading and the urine sample taken as blank. The drug should then be administered with 200 ml of water and should be followed by 200 ml given at hourly intervals for the next 4 hours. 25-Mar-19 4
  • 5.  Volunteers must be instructed to completely empty their bladder while collecting urine samples.  Frequent sampling should be done in order to obtain a good curve.  During sampling, the exact time and volume of urine excreted should be noted.  An individual collection period should not exceed one biological half-life of the drug and ideally should be considerably less.  Urine samples must be collected for at least 7 biological half- lives in order to ensure collection of more than 99% of excreted drug.  Changes in urine pH and urine volume may alter the urinary excretion rate. 25-Mar-19 5
  • 7. Determination of KE from Urinary excretion data • The first-order elimination (and excretion) rate constants can be computed from urine data by two methods 1. Rate of excretion method, and 2. Sigma-minus method. 25-Mar-19 7
  • 8. 1. RATE OF EXCRETION METHOD • The rate of urinary drug excretion(dXu/dt) is directly proportional to the amount of drug in the body(X) and written as- • Where, Ke =first order urinary excretion rate constant. • According to first-order disposition kinetics, • Substitution it in above equation yields- 25-Mar-19 8
  • 9.  Transforming the log form the equation become- 25-Mar-19 9 The above equation states that a semi log plot of rate of excretion versus time yields a straight line with slope –KE/2.303 . It must therefore be remembered that the slope of such an excretion rate versus time plot is related to elimination rate constant KE and not to excretion rate constant Ke. The excretion rate constant can be obtained from the Y-intercept (log Ke Xo). Elimination half-life and non renal elimination rate constant can then be computed from KE and Ke.
  • 10. • An advantage of excretion rate method is that for drugs having long half-lives, urine may be collected for only 3 to 4 half-lives. Moreover, there is no need to collect all urine samples since collection of any two consecutive urine samples yield points on the rate plot from which a straight line can be constructed Fig: Semi log plot of excretion rate versus mid- point time of urine collection period for computing elimination rate constant after i.v. bolus administration25-Mar-19 10